• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Does my study require an Investigational New Drug Application (IND
Does my study require an Investigational New Drug Application (IND

... function of the body and not intended for therapeutic purpose. If there is a clinical investigation intended to evaluate if a dietary supplement has the ability to diagnose, cure, mitigate, treat, or prevent a disease, an IND is required under part 312. For example, a clinical investigation designed ...
Antiepileptic Drug Selection for People with HIV/AIDS
Antiepileptic Drug Selection for People with HIV/AIDS

... People with HIV/AIDS may need many types of drugs for treatment, including seizure drugs. However, serious risks are linked to the possible drug interactions described here. Thus, it is important that people with HIV/AIDS fully understand which drugs they are taking. They also should share this info ...
An Overview of the Pharmaceutical Development Process
An Overview of the Pharmaceutical Development Process

... Asthma is a chronic disease that affects your breathing. The airways become inflamed and irritated in reaction to some kind of substance, which is called a “trigger”. The airways are the tubes that carry air and oxygen into and out of the body. Airways tend to be red and swollen and are easily irrit ...
Biopharmaceutics / Lec
Biopharmaceutics / Lec

... interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption. Thus Biopharmaceutics involves factors that influence: 1. The stability of the drug within the product. 2. ...
guidelines - Alberta Veterinary Medical Association
guidelines - Alberta Veterinary Medical Association

... The purpose of these guidelines is to summarize and clarify all existing legislation and policy regarding the compounding and prescribing of compounded products for use in animals. For the most part, the wording is a concise reflection of the text from various pieces of legislation(1, 2). However, t ...
Starpharma to Conduct Animal Trials on Vaginal Microbicide Clover
Starpharma to Conduct Animal Trials on Vaginal Microbicide Clover

... for application by women before sex to provide broadbased protection against infection by sexually transmitted diseases (STDs). Starpharma is currently preparing an Investigational New Drug application to submit to the US Food and Drug Administration (FDA) for Phase I testing of the SPL7013 gel in h ...
Syllabus - Angelina College
Syllabus - Angelina College

... Chapter 15 – Medications for Advanced Cardiovascular Life Support Orals of Drugs & Review for Finals ...
Interactions with HIV medications
Interactions with HIV medications

... coadministration of these drugs should be avoided. Levels of calcium-channel blockers (for example, Diltiazem and Verapamil) may also increase in the presence of CYP3A4 inhibitors (like PIs). These drugs are used to treat conditions such as angina (chest pain), high blood pressure, and cardiac arrhy ...
Fish oil as substitute for psychiatric drugs in children
Fish oil as substitute for psychiatric drugs in children

... to safely transit from drugs to fish oil. After the transition is completed the patients are typically symptom free and without the side effects of drugs. Vitamin E is crucial for the success of the protocol. Vitamin E (alpha tocopherol specifically) is a universal antioxidant for unsaturated double ...
week01.2.biopharm
week01.2.biopharm

... objective is to describe time vs plasma concentration profile of a drug ...
TO STUDY THE PRESCRIBING PATTERN OF ANTIPSYCHOTIC DRUGS IN A... HOSPITAL OF ASSAM.  Original Article
TO STUDY THE PRESCRIBING PATTERN OF ANTIPSYCHOTIC DRUGS IN A... HOSPITAL OF ASSAM. Original Article

... quetiapine 7 (3.28%), clozapine4(1.87%) were seen. Injectable antipsychotics were 15 of which haloperidol 11 (73.33%) and fluphenazine 4 (26.66%). Antipsychotics in combination prescription with same groups were 31 (14.90%), with antidepressants, sedative-hypnotics, anticholinergic were 168 (80.76%) ...
Practice slide 8 tafreeg 2
Practice slide 8 tafreeg 2

... moderate  deterioration of patient's status Ex: interaction causing hypokalemia ...
benzodiazepines - Website of Neelay Gandhi
benzodiazepines - Website of Neelay Gandhi

... **Low dose dependency: -benzo is prescribed for valid medical reasons -low dose intensity, no increase in doses -full patient compliance **Conventional dependency: -benzos may or may not be prescribed for valid medical reasons -increasing doses required, indicating tolerance -black market benzos may ...
Prodrugs and active metabolites among antidepressive
Prodrugs and active metabolites among antidepressive

... vitro, but metabolized by azo reduction into the true antibacterial sulfonamide; the antihistamine terfenadine metabolized to its active metabolite fexofenadine, acetanilide metabolized to paracetamol). Phase II conjugations generally produce inactive metabolites, while the well-known exception is m ...
Ototoxic Medications
Ototoxic Medications

... medications containing gentamycin or neomycin do not appear to be ototoxic in humans unless the tympanic membrane (ear drum) is perforated. When a solution of an aminoglycoside antibiotic is used on the skin together with an aminoglycoside antibiotic used intravenously, there is a risk of an increas ...
Drug disposition in pregnancy MEDSCI 722 Anna Ponnampalam
Drug disposition in pregnancy MEDSCI 722 Anna Ponnampalam

... – Interaction with other compounds ...
Introduction: Foundations for Drug Therapy
Introduction: Foundations for Drug Therapy

... • Many trade names sound alike. • The nurse should check the drug name at least three times. ...


... • They are used to relieve itching, and have the advantage of causing much less systemic effect (i.e. drowsiness) than oral ...
Chapter 2 - Veterinary Drug Development and Control
Chapter 2 - Veterinary Drug Development and Control

... Drug Compound Step 3 (cont.): • Submission and review of the New Animal Drug Application (NADA) – If application is approved, clinical trials proceed – Clinical trials are done on target species – Satisfactory clinical trial results allow scientists to file a New Animal Drug Application (NADA) with ...
Drug Metabolism Biotransformation: the process whereby lipid
Drug Metabolism Biotransformation: the process whereby lipid

... CYP1A2 is induced by cigarette smoking and consumption of charbroiled foods (active constituents are 3methylcholanthrene and benzo[a]pyrene) CYP2B6 and CYP3A4 are inducible by therapeutic drugs-phenobarbital, rifampin, and phenytoin. ...
Clinical trials - MND Association
Clinical trials - MND Association

... through the Medicines and Healthcare Products Regulatory Agency (MHRA) and for Europe via the European Medicines Agency (EMA). Licences are granted based on the evidence presented of a drug’s safety and effectiveness, which has been gained from well-designed clinical trials. Before the newly license ...
File
File

... The maximum & minimum drug conc. achieved during repeated dosing cycles.  Target Concentration : The plasma concentration required to produce desired therapeutic effect. ...
Neuro, References
Neuro, References

... a. Goodman and Gilman b. Martindale’s c. Merck Index d. Remington’s e. Trissel’s ...
Sick Day Medications In the Elderly
Sick Day Medications In the Elderly

... (longer acting) at bedtime • Reduce diazepam dose every 2-3 weeks, if withdrawal symptoms, hold at this dose until resolved • Reduce further in smaller steps (may take 4 weeks to a year) • Withdrawal effects common ...
Polypharmacy and Medication-Related Challenges in the Geriatric
Polypharmacy and Medication-Related Challenges in the Geriatric

... to longer life expectancy and the aging baby boomer population, by 2030, the number of Americans 65+ y.o. is expected to double to 71 million  85+ y.o. represent the fastest-growing segment of population  Multimorbidity • Majority of older adults have 3+ chronic ...
< 1 ... 95 96 97 98 99 100 101 102 103 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report